Strong Acthar Q + Keenova Reaffirms Acthar Guidance, Good For the ACTH Class

Research evidence excerpt

Strong Acthar Q + Keenova Reaffirms Acthar Guidance, Good For the ACTH Class

tained herein or the merits

of the securities described herein, and any representation to the contrary is an offence.

In Singapore, Jefferies Singapore Limited (“JSL”) is regulated by the Monetary Authority of Singapore. For investors in the Republic of Singapore, where this

material is prepared and issued by a Jefferies affiliate outside of Singapore, it is distributed by JSL pursuant to Regulation 32C of the Financial Advisers

Regulations. The material contained in this document is intended solely for accredited, expert or institutional investors, as defined under the Securities and

Futures Act 2001 (Singapore). If there are any matters arising from, or in connection with this material, please contact JSL, located at 80 Raffles Place #15-20,

UOB Plaza 2, Singapore 048624, telephone: +65 6551 3950. In Dubai, this material is issued and distributed by Jefferies International Limited, Dubai branch,

and is intended solely for Professional Clients and should not be distributed to, or relied upon by, Retail Clients (as defined by DFSA). A distribution of ratings in

percentage terms in each sector covered is available upon request from your sales representative. In Japan, this material is issued and distributed by Jefferies

Japan Company Limited to institutional investors only. In Hong Kong, this report is issued and approved by Jefferies Hong Kong Limited and is intended for use

only by professional investors as defined in the Hong Kong Securities and Futures Ordinance and its subsidiary legislation. In the Republic of China (Taiwan), this

report should not be distributed. The research in relation to this report is conducted outside the People’s Republic of China (“PRC”).